英国初级保健中广泛性焦虑障碍与症状的趋势:基于人群的队列研究
该研究基于英国795家全科诊所1998至2018年的THIN数据库,计算广泛性焦虑诊断与症状的年度发病率,并分析后续药物治疗。结果显示2014至2018年间18-24岁男女焦虑记录率均上升,女性从17.06升至23.33/1000人年,男性从8.59升至11.65/1000人年,焦虑抑郁复合指标也同步上升,而老年患者焦虑率保持稳定。约半数未用药患者在诊断后1年内被处方焦虑药物,最常用为选择性5-羟色胺再摄取抑制剂,苯二氮䓬类处方率持续下降。
要点
- 2014至2018年18-24岁女性焦虑记录率从17.06升至23.33/1000人年,男性从8.59升至11.65/1000人年。
- 焦虑抑郁复合指标在年轻男女中同步上升,老年女性该复合指标下降。
- 约半数未用药患者在诊断后1年内被处方焦虑药物,最常用SSRI,苯二氮䓬类处方率持续下降。
核心结论
- 英国全科医生接诊的广泛性焦虑和抑郁近期显著增加,集中在年轻人群尤其是女性。
研究设计与样本
- 基于英国795家全科诊所THIN数据库1998至2018年的基于人群的队列研究,采用泊松混合回归校正年龄、性别和诊所。
主要发现
- 2014至2018年18-24岁女性焦虑记录率从17.06升至23.33/1000人年,男性从8.59升至11.65/1000人年。
- 焦虑抑郁复合指标在18-24岁女性从49.74升至57.81/1000人年,男性从25.41升至31.45/1000人年。
- 25-34岁和35-44岁男女焦虑率也有较小幅度上升,老年患者焦虑率保持稳定。
- 约半数未用药患者在诊断后1年内被处方焦虑药物,最常用为选择性5-羟色胺再摄取抑制剂,苯二氮䓬类处方率持续下降。
关键数值与推荐
- 18-24岁女性焦虑记录率从17.06升至23.33/1000人年,男性从8.59升至11.65/1000人年(2014至2018年)。
- 18-24岁女性焦虑抑郁复合指标从49.74升至57.81/1000人年,男性从25.41升至31.45/1000人年。
- 约半数未用药患者在诊断后1年内被处方焦虑药物,最常用为选择性5-羟色胺再摄取抑制剂。
临床怎么用
- 临床应关注年轻人群尤其是女性广泛性焦虑就诊增加的趋势,及时识别和评估。
- 药物治疗以选择性5-羟色胺再摄取抑制剂为主,苯二氮䓬类使用呈下降趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Generalised anxiety disorder and symptoms are associated with poor physical, emotional and social functioning and frequent primary and acute care visits. We investigated recent temporal trends in anxiety and related mental illness in UK general practice. AIMS: The aims of this analysis are to examine temporal changes in recording of generalised anxiety in primary care and initial pharmacologic treatments. METHOD: Annual incidence rates of generalised anxiety diagnoses and symptoms were calculated from 795 UK general practices contributing to The Health Improvement Network (THIN) database between 1998 and 2018. Poisson mixed regression was used to account for age, gender and general practitioner practice. Subsequent pharmacologic treatment was examined. RESULTS: Generalised anxiety recording rates increased in both genders aged 18-24 between 2014 and 2018. For women, the increase was from 17.06 to 23.33/1000 person years at risk (PYAR); for men, 8.59 to 11.65/1000 PYAR. Increases persisted for a composite of anxiety and depression (49.74 to 57.81/1000 PYAR for women; 25.41 to 31.45/1000 PYAR for men). Smaller increases in anxiety were seen in both genders age 25-34 and 35-44. Anxiety rates among older patients remained stable, although a composite of anxiety and depression decreased for older women. About half of drug-naïve patients were prescribed anxiety drugs within 1 year following diagnosis. The most common choice was a selective serotonin reuptake inhibitor. Benzodiazepine prescription rate has fallen steadily. CONCLUSIONS: We observed a substantial increase in general practitioner consulting for generalised anxiety and depression recently, concentrated within younger people and in particular women.
引用
- Slee A, Nazareth I, Freemantle N, et al. Trends in generalised anxiety disorders and symptoms in primary care: UK population-based cohort study. Br J Psychiatry. 2021. PMID: 32895062. doi:10.1192/bjp.2020.159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。